(Q32055077)

6 July 2017

An efficient route to human bispecific IgG. (English)

1 reference

6 July 2017

Merchant AM

1

1 reference

6 July 2017

Zhu Z

2

1 reference

6 July 2017

Yuan JQ

3

1 reference

6 July 2017

Goddard A

4

1 reference

6 July 2017

Adams CW

5

1 reference

6 July 2017

Presta LG

6

1 reference

6 July 2017

Carter P

7

1 reference

6 July 2017

1 July 1998

1 reference

6 July 2017

1 reference

6 July 2017

16

1 reference

6 July 2017

677-681

1 reference

6 July 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/nbt0798-677

6 July 2017

0 references

cites work

Toward the production of bispecific antibody fragments for clinical applications

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

Engineering bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

New protein engineering approaches to multivalent and bispecific antibody fragments

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Hybrid hybridomas and their use in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Bispecific monoclonal antibodies from hybrid hybridomas

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Stable heterodimers from remodeling the domain interface of a homodimer using a phage display library

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Directed mutagenesis of dihydrofolate reductase

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Disulfide bond engineered into T4 lysozyme: stabilization of the protein toward thermal inactivation

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Conformations of disulfide bridges in proteins

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Molecular cloning and expression of an additional epidermal growth factor receptor-related gene

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Humanization of an anti-p185HER2 antibody for human cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Protein-protein recognition and the association of immunoglobulin constant domains

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Bispecific receptor globulins, novel tools for the study of cellular interactions. Preparation and characterization of an E-selectin/P-selectin bispecific receptor globulin

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Humanised monoclonal antibody therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Biological properties of a CD4 immunoadhesin

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Aligning amino acid sequences: Comparison of commonly used methods

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Progressive sequence alignment as a prerequisite to correct phylogenetic trees

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Progressive alignment and phylogenetic tree construction of protein sequences.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv

1 reference

https://api.crossref.org/works/10.1038%2FNBT0798-677

7 January 2021

Identifiers

DOI

10.1038/NBT0798-677

1 reference

Dimensions Publication ID

6 July 2017

0 references

1 reference